Tamoxifen—the oldest and the most prescribed drug in breast cancer hormonal therapy—blocks estradiol from binding to the malignant cells and inhibits the growth of estrogen receptor-positive breast cancer cells. The gene discussed is ESR1; the disease is breast cancer.